| Dr William Furrer Jr, MD | |
|
12603 Ne 36th Pl, Bellevue, WA 98005-1329 | |
| (425) 881-5808 | |
| Not Available |
| Full Name | Dr William Furrer Jr |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 12603 Ne 36th Pl, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225376684 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD 00011280 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Furrer Jr, MD 12603 Ne 36th Pl, Bellevue, WA 98005-1329 Ph: (425) 881-5808 | Dr William Furrer Jr, MD 12603 Ne 36th Pl, Bellevue, WA 98005-1329 Ph: (425) 881-5808 |
News Archive
The most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought, say a team of researchers led by Georgetown Lombardi Comprehensive Cancer Center.
Ten McGill University researchers received an important boost today, by way of the announcement of $1.7 million in new funding awarded through the Canada Foundation for Innovation's Leaders Opportunity Fund. "CFI investments are critical for our research leaders, to ensure that their research remains innovative and second to none," said Dr. Rima Rozen, Interim Vice-Principal (Research and International Relations) at McGill.
The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.
Merck today announced that it has restructured its co-development and co-commercialization agreement with ARIAD Pharmaceuticals, Inc. for ridaforolimus, an investigational orally available mTOR inhibitor currently being evaluated for the treatment of multiple cancer types, to an exclusive license agreement.
› Verified 9 days ago
Michael J Battaglia Ii, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1427 116th Ave Ne, Bellevue, WA 98004 Phone: 425-462-9800 Fax: 425-454-9143 | |
Dr. Lance S Ho, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Dean S Ricketts, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1231 116th Ave Ne, Suite 100, Bellevue, WA 98004 Phone: 425-454-5344 Fax: 425-462-0763 | |
Dr. Thomas E Trumble, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 112th Ave Ne Ste C210, Bellevue, WA 98004 Phone: 425-999-3580 Fax: 425-999-3122 | |
Mary Kathryn Thayer, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3101 Northup Way Ste 201, Bellevue, WA 98004 Phone: 425-455-3600 Fax: 425-455-3920 | |
Alan Burchard Brown, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1427 116th Ave Ne, Bellevue, WA 98004 Phone: 425-462-9800 Fax: 425-454-9143 | |
Matthew Lawrence Lyons, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3700 Fax: 425-502-3701 |